会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 73. 发明申请
    • METHOD AND SYSTEM FOR SETTING CARDIAC RESYNCHRONIZATION THERAPY PARAMETERS
    • 用于设置心脏再生治疗参数的方法和系统
    • US20110106202A1
    • 2011-05-05
    • US12987700
    • 2011-01-10
    • Jiang DingYinghong YuBruce H. KenKnight
    • Jiang DingYinghong YuBruce H. KenKnight
    • A61N1/368
    • A61N1/3627A61N1/3682A61N1/3684
    • A method or system for computing and/or setting optimal cardiac resynchronization pacing parameters as derived from intrinsic conduction data is presented. The intrinsic conduction data includes intrinsic atrio-ventricular and interventricular delay intervals which may be collected via the sensing channels of an implantable cardiac device. Among the parameters which may be optimized in this manner are an atrio-ventricular delay interval and a biventricular offset interval. In one of its aspects, the invention provides for computing optimum pacing parameters for patients having some degree of AV block or with atrial conduction deficits. Another aspect of the invention relates to a pacing mode and configuration for providing cardiac resynchronization therapy to patients with a right ventricular conduction disorder.
    • 提出了一种用于计算和/或设置从内在传导数据导出的最佳心脏再同步起搏参数的方法或系统。 内在传导数据包括可通过可植入心脏装置的感测通道收集的本征心室和室间延迟间隔。 可以以这种方式优化的参数是心房延迟间隔和双心室偏移间隔。 在其一个方面,本发明提供了对具有一定程度的AV阻滞或具有心房传导缺陷的患者计算最佳起搏参数。 本发明的另一方面涉及用于向患有右心室传导障碍的患者提供心脏再同步治疗的起搏模式和配置。
    • 74. 发明授权
    • Cardiac resynchronization method and apparatus employing mechanical measurement of cardiac walls
    • 心脏再同步化方法和采用机械测量心脏壁的装置
    • US07904155B2
    • 2011-03-08
    • US11549676
    • 2006-10-16
    • Yinghong YuJiang DingQingsheng Zhu
    • Yinghong YuJiang DingQingsheng Zhu
    • A61N1/365
    • A61N1/36578A61N1/3627A61N1/36542A61N1/3684
    • Methods and devices are disclosed for employing mechanical measurements to synchronize contractions of ventricular wall locations. Accelerometers that may be placed within electrode leads are positioned at ventricular wall locations, such as the left ventricle free wall, right ventricle free wall, and the anterior wall/septum wall. The accelerometers produce signals in response to the motion of the ventricular wall locations. A processor may then compare the signals to determine a difference in the synchronization of the ventricular wall location contractions. The difference in synchronization can be determined in various ways such as computing a phase difference and/or amplitude difference between the accelerometer signals. One or more stimulation pulses may be provided per cardiac cycle to resynchronize the contractions as measured by the accelerometers to thereby constantly and automatically optimize the cardiac resynchronization therapy.
    • 公开了用于采用机械测量来同步心室壁位置收缩的方法和装置。 可以放置在电极引线内的加速度计定位在心室壁位置,例如左心室游离壁,右心室游离壁和前壁/隔膜壁。 加速度计响应于心室壁位置的运动产生信号。 然后,处理器可以比较信号以确定心室壁位置收缩的同步的差异。 可以以各种方式确定同步差异,例如计算加速度计信号之间的相位差和/或振幅差。 可以在每个心动周期提供一个或多个刺激脉冲,以重新同步由加速度计测量的收缩,从而不断地和自动地优化心脏再同步治疗。
    • 78. 发明申请
    • METHOD AND SYSTEM FOR SETTING CARDIAC RESYNCHRONIZATION THERAPY PARAMETERS
    • 用于设置心脏再生治疗参数的方法和系统
    • US20070150013A1
    • 2007-06-28
    • US11681244
    • 2007-03-02
    • Jiang DingYinghong YuBruce KenKnight
    • Jiang DingYinghong YuBruce KenKnight
    • A61N1/362
    • A61N1/3627A61N1/3682A61N1/3684
    • A method or system for computing and/or setting optimal cardiac resynchronization pacing parameters as derived from intrinsic conduction data is presented. The intrinsic conduction data includes intrinsic atrio-ventricular and interventricular delay intervals which may be collected via the sensing channels of an implantable cardiac device. Among the parameters which may be optimized in this manner are an atrio-ventricular delay interval and a biventricular offset interval. In one of its aspects, the invention provides for computing optimum pacing parameters for patients having some degree of AV block or with atrial conduction deficits. Another aspect of the invention relates to a pacing mode and configuration for providing cardiac resynchronization therapy to patients with a right ventricular conduction disorder.
    • 提出了一种用于计算和/或设置从内在传导数据导出的最佳心脏再同步起搏参数的方法或系统。 内在传导数据包括可通过可植入心脏装置的感测通道收集的本征心室和室间延迟间隔。 可以以这种方式优化的参数是心房延迟间隔和双心室偏移间隔。 在其一个方面,本发明提供了对具有一定程度的AV阻滞或具有心房传导缺陷的患者计算最佳起搏参数。 本发明的另一方面涉及用于向患有右心室传导障碍的患者提供心脏再同步治疗的起搏模式和配置。
    • 80. 发明申请
    • Closed loop cardiac resynchronization therapy using cardiac activation sequence information
    • 闭环心脏再同步治疗使用心脏激活序列信息
    • US20060253162A1
    • 2006-11-09
    • US11125068
    • 2005-05-09
    • Yi ZhangYinghong YuAaron McCabeJiang DingJeffrey StahmannCarlos RicciScott Meyer
    • Yi ZhangYinghong YuAaron McCabeJiang DingJeffrey StahmannCarlos RicciScott Meyer
    • A61N1/365
    • A61N1/3712A61N1/3627A61N1/365G06F19/00
    • Cardiac monitoring and/or stimulation methods and systems that provide one or more of monitoring, diagnosing, defibrillation, and pacing. Cardiac signal separation is employed to detect, monitor, track and/or trend closed-loop cardiac resynchronization therapy using cardiac activation sequence information. Devices and methods involve sensing a plurality of composite cardiac signals using a plurality of electrodes, the electrodes configured for implantation in a patient. A source separation is performed using the sensed plurality of composite cardiac signals, producing one or more cardiac signal vectors associated with all or a portion of one or more cardiac activation sequences. A cardiac resynchronization therapy is adjusted using one or both of the one or more cardiac signal vectors and the signals associated with the one or more cardiac signal vectors. In further embodiments, the cardiac resynchronization therapy may be initiated, terminated, or one or more parameters of the resynchronization therapy may be altered.
    • 提供一种或多种监测,诊断,除颤和起搏的心脏监测和/或刺激方法和系统。 心脏信号分离用于使用心脏激活序列信息来检测,监测,跟踪和/或趋势闭环心脏再同步治疗。 设备和方法包括使用多个电极感测多个复合心脏信号,所述电极被配置用于植入患者体内。 使用所感测的多个复合心脏信号进行源分离,产生与一个或多个心脏激活序列的全部或一部分相关联的一个或多个心脏信号载体。 使用一个或多个心脏信号向量和与一个或多个心脏信号载体相关联的信号中的一个或两个来调整心脏再同步治疗。 在另外的实施方案中,心脏再同步治疗可以被启动,终止,或者可以改变再同步治疗的一个或多个参数。